This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
EMD Millipore
other brands :
Oncogene Research Products, Calbiochem, Novagen, Merck, Upstate Biotechnology, Chemicon, LINCO, Novabiochem, Guava
product type :
antibody
product name :
gC1q-R/p33 Antibody, NT, aa 76-93, clone 60.11
catalog :
MAB1161
quantity :
100 µg
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
60.11
reactivity :
human
application :
western blot, ELISA, immunoprecipitation, flow cytometry
citations: 1
Published Application/Species/Sample/Dilution | Reference |
---|---|
|
product information
Catalog Number :
MAB1161
Subcategory :
Inflammation & Immunology
Product Name :
Anti-gC1q-R/p33 Antibody, NT, aa 76-93, clone 60.11
Product Type :
Antibodies
Clonality :
Monoclonal Antibody
Gene ID :
Q9NPY3
Host Name :
Mouse
Antigen :
gC1q-R/p33
Clone :
60.11
Conjugate :
Purified
Isotype :
IgG1κ
Product Description :
Anti-gC1q-R/p33 Antibody, NT, aa 76-93, clone 60.11
Cross Reactivity :
Human
ALT Names :
C1q-R; C1q Receptor; Glycoprotein gC1qBP
Immunogen :
Recombinant human gC1q-R.
Specificity :
Recognizes the mature form of gC1q-R/p33 complement receptor. Antibody is directed against the amino-terminus of the receptor (residues 76-93), in the region of the receptor that binds C1q. This antibody blocks the C1q/gC1q-R interaction.
Package Size :
100 µg
Uses :
ELISA;Flow Cytometry;Immunoprecipitation;Western Blotting
Storage :
Maintain refrigerated at 2-8°C in undiluted aliquots for up to 12 months.
company information
EMD Millipore
290 Concord Road
Billerica, Massachusetts 01821
Billerica, Massachusetts 01821
bioscienceshelp@emdchemical.com
https://www.emdmillipore.com888-854-3417
headquarters: United States
EMD Millipore is the Life Science division of Merck KGaA of Darmstadt, Germany
Hundreds of New Antibodies in the areas of:
View all the new antibodies at www.emdmillipore.com.
Hundreds of New Antibodies in the areas of:
|
|
questions and comments